NDC 43598-581-01 - Buprenorphine and Naloxone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 43598-581
- Requested NDC
- 43598-581-01
- Package NDCs from labels
- 43598-581-01, 43598-581-30
- Manufacturer
- Dr.Reddys Laboratories Inc | LTS Lohmann Therapy Systems Corp. | Pharmaron Manufacturing services (UK) LTD
- Effective date
- 2026-01-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Buprenorphine and Naloxone | Dr.Reddys Laboratories Inc | LTS Lohmann Therapy Systems Corp. | Pharmaron Manufacturing services (UK) LTD | 2026-01-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43598-581-01 | Buprenorphine and Naloxone | 1 in 1 POUCH | FILM, SOLUBLE | 1 | 11 | |
| 43598-581-30 | Buprenorphine and Naloxone | 30 in 1 CARTON | FILM, SOLUBLE | 30 | 11 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43598-581-01 | EA - Each | 43598-581 | 60f82d87-d0ad-4d84-930e-4910e6b1352d | 1 | 2019-03-12 |
| 43598-581-30 | EA - Each | 43598-581 | 4964c819-812a-46b9-a7d0-9e09fb6a87d9 | 1 | 2019-03-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 02015040-9b71-4dbe-8f8d-e0d0951e8f93 | 2024-09-19 | Warnings | XF417D3PSL |
| Buprenorphine Sublingual | BUPRENORPHINE SUBLINGUAL | Direct_rx | 2204e135-6a0c-68a2-e063-6394a90ac019 | 2024-09-13 | Warnings, Adverse reactions | 56W8MW3EN1 |
| ammonia inhalants | INHALANT | Epic Medical Supply Corp | 20e849e5-8517-b9fd-e063-6394a90a0d23 | 2024-09-03 | Warnings | 5138Q19F1X |
| Multi-Phenolic | MANNOSE, 5-HYDROXYTRYPTOPHAN, ACETALDEHYDE, ACETYLCHOLINE CHLORIDE, ASCORBICUM ACIDUM, ASPARTAME, BUTYLATED HYDROXYTOLUENE, CAFFEIC ACID, CANDIDA ALBICANS, CINNAMIC ACID, CONIFERYL ALCOHOL, COUMARINUM, DOPAMINE HYDROCHLORIDE, ESTRADIOL, GABA (GAMMA-AMINOBUTYRIC ACID), GALLICUM ACIDUM, HISTAMINUM HYDROCHLORICUM, HYDROCORTISONE, INDOLUM, L-DOPA, L-PHENYLALANINE, MELATONIN, MENADIONE, NOREPINEPHRINE (BITARTRATE), PETROSELINUM CRISPUM, PHENYL ISOTHIOCYANATE, PIPERINE, PROGESTERONE, PYRROLE, QUERCETIN, | Energique, Inc. | 492b412a-01cc-48f2-bcdc-6fffcc651963 | 2024-08-23 | Warnings | 1P9D0Z171K |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | American Health Packaging | b05b0087-c0ef-40be-9bf3-3933f6cd3492 | 2024-08-20 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Quality Choice Effervescent Antacid and Pain Relief - Extra Strength | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | Chain Drug Marketing Association | 1f926637-a61c-8eb7-e063-6394a90a6502 | 2024-08-13 | Warnings | XF417D3PSL |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | American Health Packaging | 58fa9952-c8ab-4ebb-a073-15cc45f4832a | 2024-07-16 | Adverse reactions | XF417D3PSL |
| Sodium Phosphates | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC ANHYDROUS | American Regent, Inc. | dc0462ee-4486-418c-865f-e2a71bdb8e9e | 2024-06-06 | Warnings, Adverse reactions | 22ADO53M6F |
| REFL HS | ADENOSINUM TRIPHOSPHORICUM DINATRUM, NADIDUM, ARGENTUM NITRICUM, IPECACUANHA, ROBINIA PSEUDOACACIA, SULPHUR, ORIGANUM VULGARE, DUODENUM (SUIS), ESOPHAGUS (SUIS), FUNICULUS UMBILICALIS SUIS, STOMACH (SUIS), NUX VOMICA, COUMARINUM, ERYTHRAEA CENTAURIUM, PANCREAS SUIS, MURIATICUM ACIDUM, CITRICUM ACIDUM, FORMICUM ACIDUM, SARCOLACTICUM ACIDUM, COENZYME A, PROTEUS (MORGANI) | Deseret Biologicals, Inc. | 83249aee-f58b-442d-9187-6de0cf070e4d | 2024-04-29 | Warnings | XF417D3PSL |
| Glucoreg | ASCORBICUM ACIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SARCOLACTICUM ACIDUM, THIAMINUM HYDROCHLORICUM, DHEA (DEHYDROEPIANDROSTERONE), ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-LIPOICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, NADIDUM, PANTOTHENIC ACID, ACETALDEHYDE, INSULINUM (SUIS), INSULINUM (HUMAN), HEPAR SUIS, PANCREAS SUIS, PHLORIDZINUM, ALLOXANUM, BERBERIS VULGARIS, CARCINOSIN, LYCOPODIUM CLAVATUM, MOMORDICA BALSAMINA, PHOSPHORICUM ACIDUM, PHOSPHORUS, SYZYGIUM JAMBOLANUM, | Deseret Biologicals, Inc. | c77d0682-a000-4783-a91c-d4e205c34774 | 2024-04-29 | Warnings | XF417D3PSL |
| Monobasic Sodium Phosphate and Dibasic Sodium Phosphate | MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE | Lupin Pharmaceuticals,Inc. | e2fcc382-6fac-4438-ad02-ebc8528dd59a | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 22ADO53M6F |
| BUPRENORPHINE | BUPRENORPHINE | Clinical Solutions Wholesale, LLC | 2181e700-caa1-48c4-90ce-60fec053ba6a | 2024-01-09 | Warnings, Adverse reactions | 56W8MW3EN1 |
| BUPRENORPHINE | BUPRENORPHINE | Clinical Solutions Wholesale, LLC | 325532f0-276f-4689-97d6-cda879b4c758 | 2024-01-09 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | Clinical Solutions Wholesale, LLC | 273b79ac-2c62-4407-9cd1-2a2964ef13ba | 2024-01-09 | Warnings, Adverse reactions | 56W8MW3EN1 |
| A01 CELLULAR RECHARGE | ACETICUM ACIDUM, ARNICA MONTANA, AVENA SATIVA, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, CEANOTHUS AMERICANUS, CERATOSTIGMA ILLMOTTIANUM, CHININUM ARSENICOSUM, CITRICUM ACIDUM, ENGLISH ELM, EUROPEAN HORNBEAM, EUROPEAN OLIVE, GENTIANELLA AMARELLA, HYDROFLUORICUM ACIDUM, JUGLANS REGIA, LACTICUM ACIDUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NATRUM SILICOFLUORICUM, NATRUM SULPHURICUM, PASSIFLORA INCARNATA, PHOSPHORICUM ACIDUM, SARCOLACTICUM ACIDUM, SOLIDAGO VIRGAUREA | Apex Energetics Inc. | b932ebd3-afea-6a95-e053-2995a90a2735 | 2024-01-08 | Warnings | XF417D3PSL |
| A12 DTX-KIDNEY | APIS MELLIFICA, BERBERIS VULGARIS, BETULA PUBESCENS BARK, BETULA VERRUCOSA LEAF, BOS TAURUS KIDNEY, BOS TAURUS URINARY BLADDER, CITRICUM ACIDUM, CITRUS LIMONUM, FAGUS SYLVESTRIS FLOWER BUD, NATRUM MURIATICUM, PETROSELINUM SATIVUM, QUERCUS ROBUR FLOWER BUD, SINUSITISINUM, SOLIDAGO VIRGAUREA | Apex Energetics Inc. | bf52e26f-aa27-87ca-e053-2995a90a23e7 | 2024-01-08 | Warnings | XF417D3PSL |
| Buprenorphine HCl | BUPRENORPHINE HCL | Clinical Solutions Wholesale, LLC | 3a7418a2-bd6e-4082-b0fe-a5498e7b944a | 2024-01-08 | Warnings, Adverse reactions | 56W8MW3EN1 |
| N03 EXCHEM | ALLIUM SATIVUM, ARSENICUM ALBUM, BENZOICUM ACIDUM, BERBERIS VULGARIS, BETULA VERRUCOSA, CALCAREA CARBONICA, CARBOLICUM ACIDUM, CHELIDONIUM MAJUS, CHLORINUM, CITRICUM ACIDUM, HISTAMINUM, ICHTHYOLUM, JUNIPERUS COMMUNIS, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM BICARBONICUM, SODIUM HYPOCHLORITE, SOLIDAGO VIRGAUREA, SULPHUR | Apex Energetics Inc. | ba73a050-9a5d-1549-e053-2a95a90a62aa | 2024-01-08 | Warnings | XF417D3PSL |
| HEB Extra Strength Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | H. E. Butt Grocery Company | 9e502bd0-8042-8674-e053-2995a90a3d15 | 2023-12-18 | Warnings | XF417D3PSL |
| BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | Bryant Ranch Prepack | 53457b0d-3462-489e-8cf5-7cdc2ecffb48 | 2023-11-16 | Warnings, Adverse reactions | 56W8MW3EN1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.